IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 195 filers reported holding IMMUNOGEN INC in Q4 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,771,950 | -13.3% | 4,899,975 | +3.1% | 0.01% | -18.2% |
| Q2 2023 | $89,680,649 | +478.2% | 4,752,550 | +17.7% | 0.01% | +450.0% |
| Q1 2023 | $15,511,287 | +81362.6% | 4,039,396 | +5.2% | 0.00% | -33.3% |
| Q4 2022 | $19,041 | -99.9% | 3,839,090 | +3.6% | 0.00% | 0.0% |
| Q3 2022 | $17,720,000 | +6.8% | 3,707,278 | +0.6% | 0.00% | +50.0% |
| Q2 2022 | $16,586,000 | -0.1% | 3,685,781 | +5.6% | 0.00% | 0.0% |
| Q1 2022 | $16,609,000 | -36.9% | 3,489,369 | -1.6% | 0.00% | -33.3% |
| Q4 2021 | $26,317,000 | +35.9% | 3,546,767 | +3.9% | 0.00% | 0.0% |
| Q3 2021 | $19,359,000 | -19.1% | 3,414,345 | -6.0% | 0.00% | 0.0% |
| Q2 2021 | $23,938,000 | -16.0% | 3,632,576 | +3.3% | 0.00% | -25.0% |
| Q1 2021 | $28,486,000 | +45.0% | 3,516,791 | +15.4% | 0.00% | +33.3% |
| Q4 2020 | $19,650,000 | +97.0% | 3,046,603 | +9.9% | 0.00% | +50.0% |
| Q3 2020 | $9,976,000 | -22.4% | 2,771,239 | -0.9% | 0.00% | -33.3% |
| Q2 2020 | $12,857,000 | +37.9% | 2,795,189 | +2.2% | 0.00% | +50.0% |
| Q1 2020 | $9,324,000 | -62.3% | 2,734,755 | -43.5% | 0.00% | -33.3% |
| Q4 2019 | $24,708,000 | +340.0% | 4,840,030 | +108.6% | 0.00% | +200.0% |
| Q3 2019 | $5,616,000 | +19.2% | 2,320,698 | +6.9% | 0.00% | 0.0% |
| Q2 2019 | $4,710,000 | -6.8% | 2,170,841 | +16.4% | 0.00% | 0.0% |
| Q1 2019 | $5,053,000 | -69.4% | 1,864,609 | -45.7% | 0.00% | -66.7% |
| Q4 2018 | $16,490,000 | +7.4% | 3,435,540 | +112.0% | 0.00% | -25.0% |
| Q3 2018 | $15,348,000 | +3.9% | 1,620,786 | +6.8% | 0.00% | -20.0% |
| Q2 2018 | $14,771,000 | +31.7% | 1,518,162 | +42.4% | 0.01% | +25.0% |
| Q1 2018 | $11,218,000 | +83.2% | 1,066,394 | +11.6% | 0.00% | +100.0% |
| Q4 2017 | $6,122,000 | -9.5% | 955,193 | +8.0% | 0.00% | 0.0% |
| Q3 2017 | $6,765,000 | +33.4% | 884,550 | +24.0% | 0.00% | 0.0% |
| Q2 2017 | $5,070,000 | +93.1% | 713,190 | +5.1% | 0.00% | +100.0% |
| Q1 2017 | $2,625,000 | +96.5% | 678,343 | +3.5% | 0.00% | 0.0% |
| Q4 2016 | $1,336,000 | -22.0% | 655,352 | +2.5% | 0.00% | 0.0% |
| Q3 2016 | $1,713,000 | -10.5% | 639,592 | +3.0% | 0.00% | 0.0% |
| Q2 2016 | $1,913,000 | -63.8% | 621,144 | +0.1% | 0.00% | -66.7% |
| Q1 2016 | $5,285,000 | -33.8% | 620,395 | +5.4% | 0.00% | -40.0% |
| Q4 2015 | $7,988,000 | +40.5% | 588,770 | -0.6% | 0.01% | +66.7% |
| Q3 2015 | $5,687,000 | -30.8% | 592,500 | +3.7% | 0.00% | -40.0% |
| Q2 2015 | $8,217,000 | +67.0% | 571,468 | +4.0% | 0.01% | +66.7% |
| Q1 2015 | $4,919,000 | +51.2% | 549,687 | +3.0% | 0.00% | +50.0% |
| Q4 2014 | $3,254,000 | -35.9% | 533,652 | +11.3% | 0.00% | -33.3% |
| Q3 2014 | $5,076,000 | -11.1% | 479,387 | -0.6% | 0.00% | -25.0% |
| Q2 2014 | $5,712,000 | -20.4% | 482,071 | +0.3% | 0.00% | -20.0% |
| Q1 2014 | $7,172,000 | +15.6% | 480,420 | +13.5% | 0.01% | +25.0% |
| Q4 2013 | $6,206,000 | -10.7% | 423,098 | +3.7% | 0.00% | -33.3% |
| Q3 2013 | $6,947,000 | +13.6% | 408,165 | +10.7% | 0.01% | +20.0% |
| Q2 2013 | $6,115,000 | – | 368,587 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
| Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
| Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
| Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
| HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
| Grace Capital | 49,500 | $228,000 | 0.20% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
| Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
| PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |